Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
03692 HANSOH PHARMA
RT Nominal down15.380 -0.280 (-1.788%)
Ranking Overview
Buy
Ranking based on 14 research report(s)
Average Ranking 2.21
0
12
1
1
0
Previous Financial Performance
Financial Year 12/2023 EPS 55.00 RMB (cts)
Net Profit 3,277.50 RMB (MIL) DPS 19.31 RMB (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(RMB (MIL))
EPS/
((LPS)(RMB (cts))
DPS
(RMB (cts))
Net Asset Value per Share
(RMB)
Highest
(RMB (MIL))
Lowest
(RMB (MIL))
20243,633.0063.0012.55--4,196.002,887.00
20253,554.5060.0012.75--4,369.503,245.00
20264,188.0071.0013.40--4,995.903,964.00
Profit Estimation
Profit Estimation Profit / (Loss)
(RMB (MIL))
EPS*/
(LPS) (RMB (cts))
DPS *
(RMB (cts))
Broker Ranking Target Price*
(HKD)
Update Date
20243,879.0065.3013.10CITIGROUPBuy28.00 27/03/2024
20243,596.0067.06--CHINA MERCHANTSBuy25.20 05/04/2024
20243,792.9064.0021.56UOBBuy20.00 27/03/2024
20242,979.9450.00--JEFFERIES HKBuy20.00 24/10/2023
20243,175.0050.009.45MACQUARIEOutPerform19.00 26/03/2024
20243,845.0065.00--HSBCBuy18.60 02/04/2024
20243,893.0066.0018.89MORGAN STANLEYOverweight18.00 26/03/2024
20243,427.0058.0012.00CICCOutPerform17.81 28/03/2024
20243,967.0066.0010.00UBSBuy17.80 27/03/2024
20244,196.0070.8017.70BOCIBuy17.20 27/03/2024
20243,499.0059.00--CHINA RENAISSANCEBuy16.86 26/10/2023
20243,405.0058.0016.00ZHONGTAI INT'L SECADD16.70 03/01/2024
20242,887.0049.00--BOCOMNeutral14.30 22/11/2023
20243,670.0062.00--BANK OF AMERICAUnderPerform13.37 15/03/2024
 
20253,766.0063.4012.70CITIGROUP----27/03/2024
20253,891.0072.50--CHINA MERCHANTS----05/04/2024
20253,276.8355.00--JEFFERIES HK----24/10/2023
20254,369.5073.7025.60UOB----27/03/2024
20253,353.0060.0010.80MACQUARIE----26/03/2024
20253,551.0060.00--HSBC----02/04/2024
20253,480.0059.0017.54MORGAN STANLEY----26/03/2024
20253,558.0060.0024.00CICC----28/03/2024
20253,484.0058.009.00UBS----27/03/2024
20253,787.0063.9012.80BOCI----27/03/2024
20254,072.0069.00--CHINA RENAISSANCE----26/10/2023
20253,816.0065.0018.00ZHONGTAI INT'L SEC----03/01/2024
20253,245.0055.00--BOCOM----22/11/2023
20253,441.0058.10--BANK OF AMERICA----15/03/2024
 
20263,964.0066.7013.40CITIGROUP----27/03/2024
20264,995.9084.3028.29UOB----27/03/2024
20264,188.0071.00--HSBC----02/04/2024
20264,173.0069.0011.00UBS----27/03/2024
20264,311.0072.8014.60BOCI----27/03/2024
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 19/04/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Profit / (Loss) Attributable to Shareholders (K¥)RMB 3,277,503
%Change26.851%
EPS / (LPS)RMB 0.550
NBV Per Share (¥)RMB 4.347
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.